Corteva (NYSE:CTVA) Stock Sale Reported by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Corteva, Inc. (NYSE:CTVA). In a filing disclosed on November 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Corteva stock on October 14th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 11/2/2026.
• Purchased $1,001 – $15,000 in shares of argenex (NASDAQ:ARGX) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Illumina (NASDAQ:ILMN) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 10/27/2026.
• Sold $15,001 – $50,000 in shares of PTC (NASDAQ:PTC) on 10/27/2026.
• Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 10/27/2026.
• Purchased $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Micron Solutions (OTCMKTS:MICR) on 10/21/2026.
• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/21/2026.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 10/21/2026.

Corteva Stock Up 0.2%

Shares of CTVA stock opened at $12.20 on Thursday. The firm’s fifty day moving average price is $40.43 and its two-hundred day moving average price is $70.20. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1 year low of $11.24 and a 1 year high of $90.97. The firm has a market capitalization of $8.14 billion, a P/E ratio of 8.08, a PEG ratio of 1.70 and a beta of 0.58.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, November 11th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.04. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the prior year, the business posted ($0.23) EPS. The company’s quarterly revenue was down 8.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 0.760-0.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 1.05 EPS for the current fiscal year.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 1.6%. The ex-dividend date is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Bank of America lifted their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. KeyCorp raised Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target for the company in a research report on Wednesday, October 7th. UBS Group decreased their price target on Corteva to $15.00 and set a “neutral” rating for the company in a research note on Monday, October 12th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $20.00 price target on shares of Corteva in a research report on Thursday, October 8th. Finally, Zacks Research lowered Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $60.59.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Corteva during the 2nd quarter worth $4,560,180,000. Wellington Management Group LLP raised its stake in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares in the last quarter. Royal Bank of Canada raised its stake in Corteva by 202.1% in the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock valued at $624,362,000 after purchasing an additional 4,989,371 shares in the last quarter. Jupiter Topco LLC bought a new stake in Corteva during the second quarter worth about $544,246,000. Finally, Bank of America Corp DE bought a new stake in Corteva during the second quarter worth about $484,927,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.